⮝ Full datasets listing

PXD069108

PXD069108 is an original dataset announced via ProteomeXchange.

Dataset Summary
TitleMesenchymal stem cell-derived exosomes reprogram chemosensitivity pathways in cervical cancer spheroids
DescriptionCervical cancer (CC) remains a global health challenge, with chemotherapy resistance and tumor recurrence limiting treatment success. Our study investigated the effects of mesenchymal stem cell-derived exosome (MSC-Exos) pretreatment on chemotherapy sensitivity in 3D spheroids generated from HeLa and SiHa CC cell lines. Proteomic profiling of MSC-Exos revealed key proteins, including ANXA1, ANXA2, EF2, LGALS1, and PKM2, with potential roles in tumor regeneration and chemosensitization. Our findings highlight the context-dependent nature of MSC-Exo activity: while they may promote chemoresistance via drug efflux, metabolic reprogramming, and stress adaptation, they can also enhance chemosensitivity by modulating apoptosis, DNA damage response, and integrin-mediated signaling pathways. Functionally, spheroids pretreated with MSC-Exos exhibited altered responses to paclitaxel in combination with either cisplatin or carboplatin, underscoring the potential of MSC-Exos as modulators of chemotherapy response in CC. In HeLa spheroids, pretreatment with MSC-Exo significantly enhanced chemotherapy-induced cytotoxicity, evidenced by decreased cell viability, increased caspase activity, and upregulation of pro-apoptotic markers such as Bax, suggesting sensitization to apoptosis via chemotherapy. Conversely, SiHa spheroids exhibited variable responses. Although MSC-Exo pretreatment did not sensitize SiHa spheroids to paclitaxel-cisplatin, it improved responsiveness to paclitaxel–carboplatin, particularly in the spheroid core. Molecular analysis revealed upregulated SOX2 expression in SiHa spheroids, indicating partial activation of stemness pathways without full acquisition of a cancer stem cell phenotype. Overall, our findings reveal that MSC-Exo pretreatment exerts cell type- and drug-specific effects in CC spheroids. They enhance chemotherapeutic efficacy in HeLa spheroids and selectively alter drug sensitivity in more resistant SiHa spheroids. The results, therefore, represent promising candidates for engineered exosome-based adjuvant therapies in CC.
HostingRepositoryjPOST
AnnounceDate2026-04-10
AnnouncementXMLSubmission_2026-04-09_20:53:39.102.xml
DigitalObjectIdentifier
ReviewLevelPeer-reviewed dataset
DatasetOriginOriginal dataset
RepositorySupportUnsupported dataset by repository
PrimarySubmitterKittinun Leetanaporn
SpeciesList scientific name: Homo sapiens (Human); NCBI TaxID: 9606;
ModificationListS-carboxamidomethyl-L-cysteine; L-methionine sulfoxide
InstrumentOrbitrap Exploris 480
Dataset History
RevisionDatetimeStatusChangeLog Entry
02025-10-02 21:57:03ID requested
12026-04-09 20:53:40announced
Publication List
Molika P, Nittayaboon K, Kerdkumthong K, Navakanitworakul R, Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids. Int J Mol Sci, 27(3):(2026) [pubmed]
Keyword List
submitter keyword: Exosomes, Chemotherapy, Spheroids, Apoptosis, Mesenchymal stem cells, Cervical cancer, Drug Resistance
Contact List
Raphatphorn Navakanitworakul
lab head
Kittinun Leetanaporn
contact affiliationPrince of Songkla University
dataset submitter
Full Dataset Link List
jPOST dataset URI
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.jpostdb.org/JPST004104/